glp-1 anesthesia guidelines 2025 🔴 RAs and Anesthesia: Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before if asymptomatic, with extended fasting to reduce aspiration risk GLP-1 RA guidance roundup -

There is no current evidence that retatrutide reduces cardiovascular events

For now, some industry self-regulators are keeping an eye on the trend

J Clin Endocrinol Metab (2017) 102(2):43442

Regulates Blood Lipid Levels: Helps lower cholesterol and triglyceride levels, contributing to better heart health

Notably, when an acylated GCGR agonist was administered alone, it led to approximately 20% weight loss in mice on a high-fat diet, and this weight loss was further enhanced when the GCGR agonist was combined with a GLP-1R/GIPR co-agonist

In the early pathological state of AD, glucose utilization (up to 45%) is reduced, which is closely related to the alteration of insulin signaling